Moneycontrol PRO

you are here: HomeNewsBusinessCNBC-TV18 CommentsBDR Pharma lines up more compulsory licences: Sources

SHOW NAMES

Trending Topics

Sensex Live Texmaco Rail Share Price John Cockerill India Shares GK Energy IPO Opens Today iValue Infosolutions IPO Day 2

business

BDR Pharma lines up more compulsory licences: Sources

Indian generic drug maker BDR Pharma's plans could draw new battles lines over intellectual property rights. After seeking a compulsory license for leukemia drug Sprycel, BDR Pharma is setting its sight on more patent-protected anti-cancer drugs, reports CNBC-TV18's Archana Shukla.

first published: Mar 22, 2013 06:25 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347